Stock 000950 C.Q. PHARMACEUTICAL HOLDING CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News C.Q. Pharmaceutical Holding Co., Ltd.

Equities

000950

CNE0000010K0

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 09/05/2024 BST 		5-day change 1st Jan Change
5.69 CNY -0.35% Intraday chart for C.Q. Pharmaceutical Holding Co., Ltd. +4.40% +14.49%
05-06 China Grants Drug Registration Certificate to C.Q. Pharmaceutical's Anti-Inflammatory Drug MT
04-26 C.Q. Pharmaceutical Holding Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
China Grants Drug Registration Certificate to C.Q. Pharmaceutical's Anti-Inflammatory Drug
MT
C.Q. Pharmaceutical Holding Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
C.Q. Pharma's Unit Gets Nod to Market Pregabalin Capsules
MT
C.Q. Pharmaceutical Considers Potential Change in Actual Controller; Shares Jump 8%
MT
C.Q. Pharmaceutical Holding Co., Ltd. Announces Executive Appointments
CI
C.Q. Pharmaceutical Holding Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
C.Q. Pharmaceutical Holding Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
C.Q. Pharmaceutical Unit Buys Land-Use Rights in Chongqing For 51 Million Yuan
MT
C.Q. Pharmaceutical Withdraws Registration Application for Prasugrel Hydrochloride Tablets
MT
C.Q. Pharma Registers Hypertension Drug in China
MT
C.Q. Pharmaceutical Holding Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 11 July 2023
CI
C.Q. Pharmaceutical Holding Co., Ltd. Approves Cash Dividend for 2022
CI
C.Q. Pharmaceutical Holding Co., Ltd. Proposes Final Cash Dividend for 2022
CI
C.Q. Pharmaceutical Holding Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
C.Q. Pharmaceutical Holding Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
C.Q. Pharmaceutical Unit Issues 300 Million Yuan Ultra-Short-Term Loan
MT
Fosun Pharma Signs Supply and Lease Agreements With Subsidiary
MT
C.Q. Pharmaceutical Holding Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
C.Q. Pharmaceutical Holding Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
C.Q. Pharmaceutical Holding Co., Ltd. Announces Implementation of 2021 Final Profit Distribution Plan, Payable on 28 June 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 000950 Stock
  4. News C.Q. Pharmaceutical Holding Co., Ltd.